The effects of melatonin on glucose and lipids profile in type II diabetic patients
Phase 2
- Conditions
- diabetes mellitus type2.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2012062610115N1
- Lead Sponsor
- Arak university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
diabetes mellitus type II; serum Cr <2 mg/dl; HbA1c <8.5%. Exclusion criteria: melatonin consumption; pregnancy or breast feeding; current or history of epilepsy; smoking; drug addiction; alcohol or amphetamine abuse; warfarin or nifidipin medication; shifting job; history of coagulopathy or bleeding; change in diabetic or anti lipid treatment protocol; starting treatment by beta-blockers or diuretics.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood Suger. Timepoint: weeks 0,12,24. Method of measurement: laboratory.;Lipid profile. Timepoint: weeks 0,12,24. Method of measurement: laboratory.;HbA1c (%). Timepoint: weeks 0,12,24. Method of measurement: laboratory.
- Secondary Outcome Measures
Name Time Method